Panic Disorder in Clinically Referred Children and Adolescents

Department of Psychology, Assumption College, 500 Salisbury St., Worcester, MA 01609-1296, USA.
Child Psychiatry and Human Development (Impact Factor: 1.93). 07/2007; 38(1):57-71. DOI: 10.1007/s10578-006-0042-5
Source: PubMed


The present study examined the frequency and characteristics of panic disorder in children and adolescents who had been referred to a pediatric psychopharmacology clinic. Of the 280 children and adolescents evaluated in this clinic, 35 were diagnosed with panic disorder using a semi-structured clinical interview (K-SADS) and other objective measures. Approximately half of the youngsters with panic disorder also met criteria for the diagnosis of agoraphobia. There was extensive comorbidity between panic disorder and other internalizing and externalizing disorders. Parents reported clinically significant levels of child symptomatology on the CBCL. Teacher-and child-reported symptomatology on the CBCL was within the normal range. At the same time, it was notable that no child had been referred specifically for evaluation or treatment of panic disorder or agoraphobia. Implications for clinical assessment/identification and treatment are discussed.

Download full-text


Available from: Adam M Volungis, May 01, 2014
  • Source
    • " PD ( Renaud et al . 1999 ) . Another trial ( Fairbanks et al . 1997 ) examined the utility of fluoxetine for several anxiety disorders over a 6 - to 9 - week period ; 5 of 16 patients had panic disorder and 3 / 5 improved with fluoxetine treatment ( mean dose in children was 24 and 40 mg in adolescents ) . More recently , a retrospective review ( Masi et al . 2000 ) of eighteen child and adolescent outpatients with PD showed a positive response ( 83% ) to paroxetine ( 5 – 40 mg daily ) as evidenced by endpoint CGI – I scores . Limitations of this study included frequent comorbidity with other anxiety disorders and affective disorders ; paroxetine was well tolerated and there was no akathisia or d"
    [Show abstract] [Hide abstract]
    ABSTRACT: Pediatric anxiety is a prevalent psychiatric disorder that may have important implications for school, social, and academic function. Psychopharmacological approaches to the treatment of pediatric anxiety have expanded over the past 20 years and increasing empirical evidence helps guide current clinical practice. To review studies which examine the pharmacological treatment of pediatric anxiety disorders, including obsessive-compulsive disorder and to summarize treatment implications. All relevant studies were searched using MEDLINE and PsycINFO search engines, supplemented by a manual bibliographical search; studies published between 1985 and 2006 that met inclusion criteria were examined. This article provides a systematic review of the psychopharmacological treatment of pediatric anxiety disorders based on available empirical evidence, with a focus on randomized controlled trials. General treatment principles and pharmacological management of specific pediatric anxiety disorders are also reviewed. There is good evidence to support the efficacy of several pharmacological agents including the selective serotonin reuptake inhibitors to treat pediatric anxiety and obsessive-compulsive disorder, although there are still many unanswered questions.
    Psychopharmacology 04/2007; 191(1):67-86. DOI:10.1007/s00213-006-0644-4 · 3.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Trauma exposure has been associated with panic symptoms in adult samples, but little is known about the relationship between trauma and panic in children. Anxiety sensitivity (AS), or the fear of anxiety-related bodily sensations, may help explain the relationship between trauma and panic. To examine relationships among trauma, anxiety sensitivity, and panic symptoms, data were collected from youth in the New Orleans area 5–8months after Hurricane Katrina (N=302) and again 17–18months after the hurricane (N=110). At time one (T1), AS predicted panic symptoms beyond hurricane exposure. At time two (T2), AS measured at time two (T2) predicted panic symptoms beyond AS measured at T1. Clinical implications of the present findings are discussed.
    Child and Youth Care Forum 06/2009; 38(3):135-149. DOI:10.1007/s10566-009-9072-z · 1.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Panic disorder is a relatively common anxiety disorder that is often disabling. It may or may not be associated with agoraphobia. Panic disorder can be imitated by various medical illnesses, which, even when treated, can get cued with panic symptoms. It is also frequently comorbid with other psychiatric disorders including depression, generalized anxiety disorder, and substance use disorders. Although often initially seen in early adulthood, panic disorder can also present in childhood or in the geriatric population. Clinicians should thus be aware of the variability in clinical presen- tations that may be associated with both the pediatric and geriatric age groups. This article provides a broad overview of various screening and assessment tools used to evaluate panic disorder across the lifespan. The article also highlights some of the developmental differences and variability in the clinical presentation of pediatric and geriatric panic disorder.
    01/2008; 6(4). DOI:10.1176/foc.6.4.foc438
Show more